Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)EBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherReceivables RefundsShares Issued
Ratios

OptimizeRx (OPRX) Leases (2019 - 2025)

OptimizeRx (OPRX) has disclosed Leases for 7 consecutive years, with $404000.0 as the latest value for Q4 2025.

  • Quarterly Leases rose 10.38% to $404000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $404000.0 through Dec 2025, up 10.38% year-over-year, with the annual reading at $404000.0 for FY2025, 10.38% up from the prior year.
  • Leases hit $404000.0 in Q4 2025 for OptimizeRx, down from $481000.0 in the prior quarter.
  • In the past five years, Leases ranged from a high of $10.5 million in Q1 2022 to a low of $14544.0 in Q2 2023.
  • Historically, Leases has averaged $863817.4 across 5 years, with a median of $379241.0 in 2021.
  • Biggest five-year swings in Leases: tumbled 97.98% in 2023 and later soared 3145.32% in 2024.
  • Year by year, Leases stood at $328820.0 in 2021, then fell by 28.44% to $235320.0 in 2022, then skyrocketed by 143.5% to $573000.0 in 2023, then tumbled by 36.13% to $366000.0 in 2024, then grew by 10.38% to $404000.0 in 2025.
  • Business Quant data shows Leases for OPRX at $404000.0 in Q4 2025, $481000.0 in Q3 2025, and $528000.0 in Q2 2025.